Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
https://www.nature.com/articles/s41443-022-00568-2.pdf
Reference38 articles.
1. Hussein AA, Alwaal A, Lue TF. All about Peyronie’s disease. Asian J Urol. 2015;2:70–8. https://doi.org/10.1016/j.ajur.2015.04.019.
2. Nelson CJ, Mulhall JP. Psychological impact of Peyronie’s disease: a review. J Sex Med. 2013;10:653–60. https://doi.org/10.1111/j.1743-6109.2012.02999.x.
3. Sharma KL, Alom M, Trost L. The etiology of Peyronie’s disease: pathogenesis and genetic contributions. Sex Med Rev. 2020;8:314–23. https://doi.org/10.1016/j.sxmr.2019.06.004.
4. Aditya I, Grober ED, Krakowsky Y. Peyronie’s disease and testosterone deficiency: Is there a link? World J Urol. 2019;37:1035–41. https://doi.org/10.1007/s00345-019-02723-9.
5. Ventimiglia E, Capogrosso P, Colicchia M, Boeri L, Serino A, La Croce G, et al. Peyronie’s disease and autoimmunity—a real-life clinical study and comprehensive review. J Sex Med. 2015. https://doi.org/10.1111/jsm.12825.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Multidimensional assessment of adverse events of finasteride: a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024;2024-08-22
2. Post‐finasteride syndrome: real or myth?;Trends in Urology & Men's Health;2024-06-18
3. The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database;Brain Sciences;2023-11-29
4. A clinical guide to rare male sexual disorders;Nature Reviews Urology;2023-09-05
5. Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis;Frontiers in Aging;2023-06-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3